izpis_h1_title_alt

Sentinel node biopsy for conjunctival melanoma : single centre experience and review of current literature
ID Perić, Barbara (Author), ID Leiler, Špela (Author), ID Hawlina, Gregor (Author), ID Jančar, Boris (Author), ID Snoj, Marko (Author), ID Perhavec, Andraž (Author)

.pdfPDF - Presentation file, Download (538,49 KB)
MD5: 3E6B061CA0F086B66016F67358E6D78D
URLURL - Source URL, Visit https://journals.sagepub.com/doi/10.1177/10732748211042116 This link opens in a new window

Abstract
Purpose: To evaluate the role of sentinel lymph node (SLN) biopsy in patients with conjuctival melanoma (CjM). Study design: Retrospective observational cohort study and literature review. Subjects: Slovenian patients with CjM are included in the study. Methods: Prospectively collected data of CjM patients treated from June 2005 to December 2016 were retrospectively analyzed. Main outcome measures: The numbers of SLN biopsy procedures, positive and false positive SLN, and local and regional relapses have been described together with overall survival. Results: From June 2005 until December 2016, 24 patients with CjM were treated. The median follow-up time was 65.3 months. The mean Breslow thickness was 1.5 mm (sd = 1.8 mm), and ulceration was present in 29% of cases. Altogether, 14/24 (58%) SLN biopsy procedures were performed. SLN was positive in 2/14 (14%) cases. The estimated 5-year overall survival (OS) of the group was 72.5%, with a median survival of 151 months (95% CI 77–224). From January 2013 to January 2020, five (5/140, 3%) authors reported results comparable to our study. Conclusion: Our results confirm that CjM is a rare disease with approximately 14% of positive SLN. At the moment, there are no firm conclusions regarding who would benefit most from SLN biopsy or whether or not CLND should be offered. Data from literature emphasize the need for consistent and uniform staging and future multicentric studies.

Language:English
Keywords:conjuctival melanoma, sentinel node biopsy, lymphadenectomy, survival
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2021
Number of pages:8 str.
Numbering:Vol. 28
PID:20.500.12556/RUL-144175 This link opens in a new window
UDC:617.7
ISSN on article:1526-2359
DOI:10.1177/10732748211042116 This link opens in a new window
COBISS.SI-ID:82235907 This link opens in a new window
Publication date in RUL:02.02.2023
Views:659
Downloads:67
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Cancer control
Shortened title:Cancer control
Publisher:SAGE, Moffitt Cancer Center
ISSN:1526-2359
COBISS.SI-ID:523832601 This link opens in a new window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Secondary language

Language:Slovenian
Keywords:konjuktivni melanom, biopsija, limfadenektomija, preživetje, očesne bolezni

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back